Project QUIT+: Adapting and Testing a Smoking Cessation Intervention for Transgender and Gender Expansive Individuals | MicrobiomeTrials← Back to trialsNCT06654414
Project QUIT+: Adapting and Testing a Smoking Cessation Intervention for Transgender and Gender Expansive Individuals
TERMINATEDNAINTERVENTIONAL
Trial Details
Start: 2024-09-01Est. Completion: 2025-03-18
Enrollment target: 3 participants Locations- Massachusetts General Hopsital, Boston, Massachusetts, United States
- Boston University - Charles River Campus, Boston, Massachusetts, United States
- Fenway Health, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
Smoking
Background: It is important to quickly identify when people are at risk of smoking. Most current methods rely on people …
Kansas City, United StatesCompleted Apr 30, 2027
Smoking CessationCigarette SmokingTobacco UseNicotine Dependence
This pilot randomized controlled trial will test the feasibility of a smoking cessation intervention using mindful smoki…
Minneapolis, United StatesEst. completion Dec 31, 2027
Recruiting
The goal of this clinical trial is to learn if a personalized, brain-scan-guided form of transcranial magnetic stimulati…
Newark, United StatesEst. completion Jul 15, 2029